Medication Therapy Problems in Hospitalized Patients with Decreased Kidney Function Across the Spectrum of Kidney Disease: A Scoping Review
Journal of Clinical Medicine · 29.03.2026 · 15 (7) · 2606
DOI: 10.3390/jcm15072606 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.03.2026. Verfasst von Tomona Iso und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Loma Linda University, 24745 Stewart Street, Loma Linda, CA 92350, USA. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This scoping review aimed to identify gaps in the literature regarding medication therapy problems (MTPs) among hospitalized adults with decreased kidney function. Specifically, it aimed to answer the following questions: (1) What types of MTPs have been reported? (2) What is the reported prevalence of MTPs? (3) Do MTPs differ by type of kidney disease? (4) What gaps exist regarding MTPs and pharmacists’ involvement?
Methods
Studies involving adult patients with decreased kidney function that investigated MTPs were included. Studies focused exclusively on post-transplant care, chemotherapy, or a single MTP type were excluded. Literature searches were conducted in PubMed, EMBASE, Cochrane Library, Web of Science, and International Pharmaceutical Abstracts. Two independent reviewers screened and extracted data, with a third reviewer resolving discrepancies. All identified MTPs were re-categorized using the Pharmacy Quality Alliance (PQA) framework and the Pharmaceutical Care Network Europe (PCNE) classification.
Results
A total of 23 studies met the inclusion criteria, including two conference proceedings, encompassing 7151 patients. The most common MTP framework was the PCNE classification (13 studies, 57%). Reclassification using the PQA yielded 10,596 MTPs, most frequently “Safety—dosage too high” (n = 2464) and “Effectiveness—dosage too low” (n = 2262). Reclassification using the PCNE yielded 11,574 MTPs, most frequently “Drug selection” (n = 6974) and “Dose selection” (n = 2636). All studies involved patients with chronic kidney disease (CKD), and two also included acute kidney injury (AKI).
Conclusions
Dosage-related MTPs were most prevalent among hospitalized patients with decreased kidney function. Variability in MTP definitions, limited representation of patients with AKI and AKD, and minimal reporting on pharmacists’ roles reveal important gaps. Addressing these gaps through standardized MTP classification and further research in understudied kidney disease populations may enhance patient safety and support clinical pharmacists’ contributions to optimizing medication safety across the kidney disease continuum.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Loma Linda University, 24745 Stewart Street, Loma Linda, CA 92350, USA.
ORCID-Profile: Tomona Iso, Lisa Hong
Zitieren
APA
Iso, T., Antwan, D., Galima, M., Manlongat, M., Marogy, S., Ndrekaj, R., & Hong, L. (2026). Medication Therapy Problems in Hospitalized Patients with Decreased Kidney Function Across the Spectrum of Kidney Disease: A Scoping Review. Journal of Clinical Medicine, 15(7), 2606. https://doi.org/10.3390/jcm15072606
Vancouver
Iso T, Antwan D, Galima M, Manlongat M, Marogy S, Ndrekaj R, et al. Medication Therapy Problems in Hospitalized Patients with Decreased Kidney Function Across the Spectrum of Kidney Disease: A Scoping Review. Journal of Clinical Medicine. 2026;15(7):2606. doi:10.3390/jcm15072606
BibTeX
@article{Iso2026,
author = {Iso, Tomona and Antwan, Danielle and Galima, Melanie and Manlongat, Monarc and Marogy, Safer and Ndrekaj, Redi and Hong, Lisa},
title = {Medication Therapy Problems in Hospitalized Patients with Decreased Kidney Function Across the Spectrum of Kidney Disease: A Scoping Review},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {7},
pages = {2606},
doi = {10.3390/jcm15072606}
}
EUVIMED